More than 200 million people worldwide have peripheral artery disease (PAD) or its most
severe manifestation, critical limb ischemia (CLI). While endovascular treatment has become …

Objective Atherectomy has become increasingly used as an endovascular treatment of
lower extremity atherosclerotic disease in the United States. However, concerns and …

Background The long-term outcome of Jetstream atherectomy (JA) with or without adjunctive
drug coated balloons (DCB) in a real-world setting remains unknown. We report 16-month …

Purpose: To examine whether the combination of orbital atherectomy (OA) and drug-coated
balloons (DCB) can lead to superior procedural and 2-year outcomes compared with DCB …

Background Plain balloon angioplasty has traditionally been used to treat lower limb arterial
disease but can be limited by significant residual stenosis, vessel recoil, dissection, and by …

Background Femoropopliteal (FP) artery is one of the most anatomically challenging areas
for sustained stent patency. The incidence of FP in‐stent restenosis (ISR) is estimated at …

This study aimed to evaluate the efficacy and safety of excimer laser coronary atherectomy
(ELCA) prior to paclitaxel-coated balloon angioplasty for de novo coronary artery lesions …

Objective Our study aimed to perform a meta-analysis based on current evidence to
investigate the efficacy of different debulking devices in the treatment of femoropopliteal in …

Background and Objectives: In patients with peripheral artery disease, there is insufficient
understanding of characteristics that predict successful revascularization of the lower …

Despite the development of new therapies for the treatment of femoropopliteal disease,
nitinol stents remain a mainstay of therapy following balloon angioplasty. Consequently …